FX.co ★ Denmark's Central Bank Cuts 2025–2027 GDP Outlook

Denmark's central bank has revised its GDP forecasts for the years 2025 to 2027, adjusting them downward due to the adverse effects of U.S. trade tariffs and diminished growth in the pharmaceuticals sector, as international competition intensifies. The Danish economy is now projected to grow by 2.0% in both 2025 and 2026, a decrease from the previous estimates made in June, which anticipated growth rates of 3.6% and 2.3%, respectively. For 2027, GDP growth is now predicted to be 1.7%, revised from an earlier forecast of 2.0%. Contributing to this challenging economic environment, Novo Nordisk, renowned for its popular drug, Wegovy, has faced a tumultuous year characterized by stagnant sales growth, profit warnings, and a dramatic $400 billion loss in market value. This has resulted in the layoff of approximately 9,000 employees, over half of whom were based in Denmark. Preliminary figures from Statistics Denmark reveal that while the economy grew by 1.9% in the second quarter of 2025, this marks a slowdown from a 2.5% expansion in the preceding quarter.